Related Experiment Videos

Implantable defibrillation and thromboembolic events

G Benedini1, A Marchini, A Curnis

  • 1University of Brescia, Italy.

Insights

Thromboembolic events (TEEs) can occur in patients with implantable cardioverter-defibrillators (ICDs). This study found TEEs in 6.5% of patients, highlighting potential risks during follow-up.

Area of Science:

  • Cardiology
  • Medical Devices
  • Thrombosis

Background:

  • Thromboembolic events (TEEs) are known complications associated with implantable cardioverter-defibrillators (ICDs).
  • Understanding the incidence and etiology of TEEs in ICD patients is crucial for patient management.

Observation:

  • Four cases of TEEs (two peripheral, two cerebral) were observed in a series of ICD patients.
  • These events occurred during a mean follow-up of 19.4 months.
  • Affected patients had chronic postinfarction left ventricular (LV) aneurysm or idiopathic dilated cardiomyopathy, with no prior embolism history or detectable LV clots.

Findings:

  • The incidence of TEEs in this cohort was 6.5%.
  • No atrial fibrillation episodes were documented before or after ICD implantation.
  • The study identified potential causes for embolization in this patient group.

Implications:

  • The findings suggest a need for careful consideration of thromboembolic risk in ICD recipients, even without traditional risk factors.
  • Further research into the suitability and efficacy of anticoagulant therapy in ICD patients is warranted.
  • This study contributes to the understanding of TEEs in the context of ICD implantation and management.

Related Concept Videos